Trending...
- Making Time for Mythic Adventure - 193
- 'Nightmare' Star Mckenna Bridger Talks Psychological Thriller, Two-Part Shoot And Taking On Violet Adams - 130
- California: Governor Newsom signs new law to protect workers, require disclosures on AI-generated advertising - 119
WEST HOLLYWOOD, Calif. - Californer -- Simufilam is a leading candidate to become the first effective treatment for Alzheimer's Disease. In an analysis by sfbanc financial, Cassava Sciences, Inc. (SAVA) was upgraded as a Strong Buy, from 8/10 to 9.5/10.
The drug in development purportedly works by retiring the proper conformation of filamin A, a molecule involved in the cascade of Alzheimer's disease. Open-label results are showing effectiveness in 84% of subjects treated. These promising results, along with recent insider buying, has led the sfbanc community to upgrade the stock.
More on The Californer
Additional results from the open label trial are expected by the end of this year. Call volume shows optimism for the results of the Cognitive Maintenance Study (CMS) in late 2023. This trial will include 100 subjects randomized to switch from active drug to placebo. Simufilam is currently in two randomized placebo-controlled Phase 3 trials.
sfbanc is a financial community that provides analysis and discussion of available public information in the finance sector. https://sfbanc.com
The drug in development purportedly works by retiring the proper conformation of filamin A, a molecule involved in the cascade of Alzheimer's disease. Open-label results are showing effectiveness in 84% of subjects treated. These promising results, along with recent insider buying, has led the sfbanc community to upgrade the stock.
More on The Californer
- Rentacomputer.com Highlights On-Stage Teleprompter Rentals for Lyrics, Scripts, and Cues
- Treo expands global distribution across 17+ streaming FAST and connected TV platforms
- California: Governor Newsom announces Judicial Appointments 9.18.2026
- Mystery Enterprises Receives Federal Trademark Registration for Automated Murder Mystery Game Format
- Matt Zavala of Zavala Law, PC Selected to the 2027 Super Lawyers List
Additional results from the open label trial are expected by the end of this year. Call volume shows optimism for the results of the Cognitive Maintenance Study (CMS) in late 2023. This trial will include 100 subjects randomized to switch from active drug to placebo. Simufilam is currently in two randomized placebo-controlled Phase 3 trials.
sfbanc is a financial community that provides analysis and discussion of available public information in the finance sector. https://sfbanc.com
Source: sfbanc
1 Comment
- J Hautau:
SAVA🚀 no side effects. Promising.
Latest on The Californer
- Senior Travel Deal Of The Week: 16-Day Morocco Adventure Drops From $4,295 To $995
- Ragin' Cajun Announces New Cheeseburger Seasoning on National Cheeseburger Day
- Warrant Activity, AVERSAâ„¢ Progress and a Potentially Transformative Fall Take Center Stage: Nutriband Inc. (N A S D A Q: NTRB)
- California: Governor Newsom issues executive order to accelerate independent oversight and advance the creation of an AI kill switch
- Manuel Jesse Lopez Expands Amazon Influencer Storefront To Global Audience
- xBxBio Opens EU, Asia and Latin America Regulatory Leadership Searches
- TitleChain Foundation Opens Public Commons Reference Project for Real-World Asset Transfer
- Put Your Herd on Your Phone: Kiko Nation Makes Livestock Management Simple
- Chapter Enterprise and NuGuard AI Announce Strategic Partnership to Make Enterprise Agentic AI Both Role-Intelligent and Audit-Ready
- iSmile Orthodontics - San Ramon Trains Its Whole Team on AI, Invites Other Practices to Join
- Future Intelligence Think Tank Surpasses 1,000 Members Exploring Human and Artificial Intelligence
- Manuel Jesse Lopez Launches Official Amazon Influencer Storefront to Streamline Consumer Purchases
- Connect Names Zeb Hastings Head of Partnerships & Growth
- Server Memory Up 27 Percent Since March While DDR4 Falls 25 Percent: eRacks Publishes Its Tracking
- Sons of Morehouse Carry the Light: David Roach and Larry Calhoun Keep Independent Black Stories Alive from Stage to Screen
- Humphrey Jr. Returns Brings a Beloved Northern California Whale Story to a New Generation
- mQOL Announces Jessica Willoughby as Chief Operating Officer
- Wheelchair to Founder: At 70, Jonine Scott Turns a Personal Health Crisis Into Luna Select Market
- California: Governor Newsom announces appointments 9.17.2026
- California: Governor Newsom proclaims Constitution Day and Citizenship Day